Diaceutics up 7% on strong revenue growth and positive outlook
- Revenue up 40% driven by rapid adoption of subs- Average revenue per brand £0.3m- potential for £3m- Two-year investment plan to drive enhanced growthDiagnostics commercialisation platform provider Diaceutics (DXRX:AIM)...
17 April 2023